First-in-man safety evaluation of renal denervation for chronic systolic heart failure: Primary outcome from REACH-Pilot study

International Journal of Cardiology

Volumn 162, Issue 3, 2013, Pages 189-192

  Davies, Justin E ^a   Manisty, Charlotte H ^a   Petraco, Ricardo ^a   Barron, Anthony J ^a   Unsworth, Beth ^a   Mayet, Jamil ^a   Hamady, Mohamad ^a   Hughes, Alun D ^a   Sever, Peter S ^a   Sobotka, Paul A ^b   Francis, Darrel P ^a  

^a NATIONAL HEART AND LUNG INSTITUTE   (United Kingdom)

^b OHIO STATE UNIVERSITY   (United States)

Author keywords

Blood pressure; Renal denervation; Sympathetic nervous system; Sympathetic overactivation; Systolic heart failure

Indexed keywords

AGED; ARTICLE; BLOOD PRESSURE; CHRONIC DISEASE; CLINICAL ARTICLE; CLINICAL PROTOCOL; FEMALE; FOLLOW UP; HEART HEMODYNAMICS; HOSPITAL ADMISSION; HOSPITALIZATION; HUMAN; KIDNEY DENERVATION; KIDNEY FUNCTION; MALE; PATIENT ASSESSMENT; PATIENT SAFETY; PILOT STUDY; PRIORITY JOURNAL; SYSTOLIC HEART FAILURE; TREATMENT RESPONSE; ADRENERGIC SYSTEM; BLOOD PRESSURE MEASUREMENT; CONTROLLED STUDY; CREATININE BLOOD LEVEL; DIASTOLIC BLOOD PRESSURE; DRUG MECHANISM; EXERCISE; FAINTNESS; MORBIDITY; MORTALITY; PROGNOSIS; SAFETY; SYMPTOMATOLOGY; SYSTOLIC BLOOD PRESSURE; UREA BLOOD LEVEL;

AGED; CHRONIC DISEASE; DENERVATION; FEMALE; FOLLOW-UP STUDIES; HEART FAILURE, SYSTOLIC; HUMANS; KIDNEY; MALE; MIDDLE AGED; PATIENT SAFETY; PILOT PROJECTS; TREATMENT OUTCOME;

AMLODIPINE; BISOPROLOL; BUMETANIDE; CANDESARTAN; CREATININE; FUROSEMIDE; IRBESARTAN; LISINOPRIL; LOSARTAN; PERINDOPRIL; SPIRONOLACTONE; UREA;

EID: 84872500794     PISSN: 01675273     EISSN: 18741754     Source Type: Journal    
DOI: 10.1016/j.ijcard.2012.09.019     Document Type: Article

References (11)

1. M. Petersson, P. Friberg, G. Eisenhofer, G. Lambert, and B. Rundqvist Long-term outcome in relation to renal sympathetic activity in patients with chronic heart failure Eur Heart J 26 2005 906 913
2. G.J. Hasking, M.D. Esler, G.L. Jennings, and D. Burton Norepinephrine spillover to plasma in patients with congestive heart failure: evidence of increased overall and cardiorenal sympathetic nervous activity Circulation 986 73 1986 615 621
3. H.D. Schultz, Y.L. Li, and Y. Ding Arterial chemoreceptors and sympathetic nerve activity Hypertension 50 2007 6 13 (2007)
4. P.A. Sobotka, H. Krum, M. Böhm, D.P. Francis, and M.P. Schlaich The role of renal denervation in the treatment of heart failure Curr Cardiol Rep 14 2012 285 292
5. H. Krum, M. Schlaich, R. Whitbourn, P.A. Sobotka, J. Sadowski, and K. Bartus Catheter-based renal sympathetic denervation for resistant hypertension: a multicentre safety and proof-of-principle cohort study Lancet 373 2009 1275 1281
6. Symplicity HTN-2 Investigators M.D. Esler, H. Krum, P.A. Sobotka, M.P. Schlaich, and R.E. Schmieder Renal sympathetic denervation in patients with treatment-resistant hypertension (The Symplicity HTN-2 Trial): a randomised controlled trial Lancet 376 2010 1903 1909
7. I.H. Zucker Novel mechanisms of sympathetic regulation in chronic heart failure Hypertension 48 2006 1005 1011
8. T. Nozawa, A. Igawa, N. Fujii, B.-I. Kato, N. Yoshida, and H. Asanoi Effects of long-term renal sympathetic denervation on heart failure after myocardial infarction in rats Heart Vessels 16 2002 51 56
9. The CONSENSUS Trial Study Group Effects of enalapril on mortality in severe congestive heart failure. Results of the Cooperative North Scandinavian Enalapril Survival Study (CONSENSUS) N Engl J Med 316 1987 1429 1435
10. SOLVD Investigators Effect of enalapril on survival in patients with reduced left ventricular ejection fractions and congestive heart failure N Engl J Med 325 1991 293 302
11. M.A. Pfeffer, K. Swedberg, C.B. Granger, P. Held, J.J. McMurray, and E.L. Michelson Effects of candesartan on mortality and morbidity in patients with chronic heart failure: the CHARM-Overall programme Lancet 362 9386 2003 759 766